Please login to the form below

Not currently logged in
Email:
Password:

antifibrotic therapy

This page shows the latest antifibrotic therapy news and features for those working in and with pharma, biotech and healthcare.

Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data

Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data

taking existing antifibrotic therapy,” said Luca Richeldi, Professor of respiratory medicine at the Università Cattolica del Sacro Cuore in Rome, Italy and the principal investigator on the trial. ... In February 2022, the treatment was granted

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Havas Life Medicom

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....